Fidelity Advisor Health Care C EBIT

As of the most recent data (January 2024), FHCCX shows a EBIT of $66M. That compares with $63M in the prior-year period — up 5.7% year over year. That is below the sector sector average of $2.5T. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, FHCCX's EBIT is now $66M (was $63M) — a 5.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Fidelity Advisor Health Care C is outperforming or lagging.

The its sector sector average EBIT is about $2.5T. Fidelity Advisor Health Care C is at $66M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how FHCCX stacks up against individual peers as well.

Tracking FHCCX's ebit over time shows whether Fidelity Advisor Health Care C is scaling, shrinking, or reshaping that part of the business. The current reading is $66M That compares with $63M in the prior-year period — up 5.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Fidelity Advisor Health Care C's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $66M) with ownership activity and broader fundamentals.